Breaking News

DSTC, InSilicoTrials Partner to Innovate Drug Development

Will combine expertise in an effort to cut the cost and time-to-market, increase safety and reduce animal and human testing.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

DSTC, a Japanese preclinical CRO known for its ion channel assay capabilities, and European Life science tech company InSilicoTrials, entered a partnership to provide the Japanese pharmaceutical industry with access to innovative services that leverage cutting-edge technology such as modeling and simulation.   DSTC and InSilicoTrials will combine their expertise to advance innovation and digitalization, following the recommendations of regulatory bodies, including the FDA, EMA and PMDA, in an ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters